376 related articles for article (PubMed ID: 17316578)
1. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.
Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M
J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428
[TBL] [Abstract][Full Text] [Related]
4. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
Ding G; Jiang Q; Zhang L; Zhang Z; Knight RA; Soltanian-Zadeh H; Lu M; Ewing JR; Li Q; Whitton PA; Chopp M
J Neurol Sci; 2004 Aug; 223(2):135-43. PubMed ID: 15337614
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Jiang P; Divine GW; Knight RA; Chopp M
J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789
[TBL] [Abstract][Full Text] [Related]
11. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
Lu HT; Zhao JG; Li MH; Li YD
Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
[TBL] [Abstract][Full Text] [Related]
12. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
Copin JC; Gasche Y
Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
[TBL] [Abstract][Full Text] [Related]
13. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M
J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772
[TBL] [Abstract][Full Text] [Related]
14. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
16. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.
Henninger N; Bratane BT; Bastan B; Bouley J; Fisher M
J Cereb Blood Flow Metab; 2009 Jan; 29(1):119-29. PubMed ID: 18766195
[TBL] [Abstract][Full Text] [Related]
17. Monteplase reduces infarct volume and hemorrhagic transformation in rat model of embolic stroke.
Muramatsu H; Igarashi H; Okubo S; Katayama Y
Neurol Res; 2002 Apr; 24(3):311-6. PubMed ID: 11958428
[TBL] [Abstract][Full Text] [Related]
18. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Romanos E; Planas AM; Amaro S; Chamorro A
J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
[TBL] [Abstract][Full Text] [Related]
19. Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain.
Franke C; Brinker G; Pillekamp F; Hoehn M
J Cereb Blood Flow Metab; 2000 Mar; 20(3):583-91. PubMed ID: 10724122
[TBL] [Abstract][Full Text] [Related]
20. Thrombolytic therapy for acute ischemic stroke.
Kelley RE
J La State Med Soc; 2000 May; 152(5):253-8. PubMed ID: 10875215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]